Shanghai Lianmin Biochemical Co.LTD
ABOUT US
Shanghai Lianmin Biochemical Co. LTD was established in the early stages of reform and opening up, formerly known as Shanghai Lianmin Reagent Factory. In 1996, it was transformed into a joint-stock enterprise and fully controlled by natural persons.
In 2009, the company purchased land on Hill 49/20 in Block 13 of Qingpu Industrial Park (legal address: No. 1-4, Lane 1428, Huijin Road, Chonggu Town, Qingpu District, Shanghai), covering an area of 5363.9 square meters. Planning and construction began in 2010. The construction was completed and fully put into use by the end of 2012.
In 2013, the company decided to apply for veterinary drug raw materials in accordance with the requirements of the "Quality Management Standards for Veterinary Drug Production" (revised in 2002), including chorionic gonadotropin, chloroprostenol, and chloroprostenol sodium. We applied on June 8, 2014 and obtained the GMP certificate for veterinary drug production on December 27, 2014. Our company has become a legitimate producer of animal medicine raw materials.
In 2019, we passed GMP retesting and added products such as Gonarelin, Luteinizing Hormone Releasing Hormone A2, and Luteinizing Hormone Releasing Hormone A3.
The current total number of employees in the company is 34. Belonging to: quality, production, warehousing, sales, finance, and comprehensive administrative departments. Among them, professional and technical personnel account for approximately 55.88% of the total number of employees.
CULTURE
Corporate Purpose
Adhere to the law, speak with conscience, and keep promises
Corporate Mission
Enter the production state and implement GMP at each stage
Corporate Objectives
Make all users feel at ease with our products
Product Quality Management
Quality is the life of an enterprise. The quality awareness of a veterinary medicine enterprise is of utmost importance in enterprise management. Since obtaining the GMP certificate for veterinary drugs in December 2014, the company has always been guided by the awareness of "paying attention to details, continuous improvement, quality, and ensuring safety", and guided by the "Good Manufacturing Practice for Veterinary Drugs". In order to increase the company's market competitiveness, we focus on improving product quality by paying attention to details and continuously improving processes. In 2017, we raised the quality standards for intermediates, and the content standard for chloroprostenol finished products increased from 92.0% to 96.0%. According to market demand, we have expanded the batch size, thereby reducing operating costs and improving profitability.
Basic information of the original project
Shanghai Lianmin Biochemical Co. LTD is located at No. 1-4, Lane 1428, Huijin Road, Chonggu Town, Qingpu District, Shanghai. There are 4 main buildings and 4 auxiliary buildings jointly built in the factory area, all of which are reinforced concrete structures.
The veterinary drug raw material production workshop (Building 3) covers an area of 30 meters in length, 15 meters in width, and 461 square meters. Building 3 is a three story building with a building area of 1436.06 square meters. The total height of the workshop is 15.5 meters. The ground floor is a clean raw material workshop, (sandwiched by two floors) is a technical mezzanine and employee changing room, the third floor is a velvet stimulating hormone crude workshop, and the fourth floor is a chloroprostenol&chloroprostenol sodium crude workshop. Among them, the key production workshop is the C-level clean production workshop for refining veterinary drug raw materials (1st floor of Building 3), which produces the final products of follicle stimulating hormone, chloroprostenol, chloroprostenol sodium, gosaurin, luteinizing hormone releasing hormone A2, and luteinizing hormone releasing hormone A3. The veterinary drug raw material production workshop (Building 2) covers an area of 30m in length, 15m in width, and 461m2. The second floor of Building 2 is an employee changing room, and the third floor is a peptide synthesis workshop.
The experimental animal room for testing (part of the first floor of Building 1) covers a length of 17m, a width of 7.8m, and an area of 132.6m2. To ensure the environmental requirements of the experimental animals, an experimental animal barrier area is set up.
The Quality Testing Center and Microbial Testing Center (3rd and 4th floors of Building 1) are 30m long and 17m wide, with a total usable area of 700m2 on the 3rd and 4th floors. The overall floor area of the 3rd floor is divided into separate zones for the Quality Testing Center and Microbial Testing Center. The fourth floor is the testing function room of the quality inspection center.
In addition, there are warehouses for raw materials, packaging materials, dangerous goods, and finished products that meet the requirements of animal medicine GMP.
New product plan and production scale
In response to market demand, product matching, and company development, our company plans to increase the production line of D-chloroprostenol sodium. The D-chloroprostenol sodium workshop is located on the fourth floor of Building 3.
Production is planned based on market demand.
All employees of our company will continue to implement the corporate mission and strive for continuous improvement in order to achieve the mission and goals of the enterprise, under the care of the government's support policies for private enterprises and the guidance of higher-level departments.
APTITUDE
2014
May 27, 2015
2019
August 2021
After 2021
2025
Veterinary Drug GMP Certificate
The company's animal medicine raw material production line has passed the original Ministry of Agriculture's animal medicine GMP certification for the first time, becoming one of the earliest domestic enterprises to obtain the production qualification for this category, laying a core foundation for the subsequent large-scale implementation of animal medicine business
Approval number for veterinary drug raw materials
Chlorpromazine Sodium has been approved with the document number (2015) 090342202, which is the first publicly available official approval number for animal drug raw materials in the enterprise
Re examination of GMP certificate for veterinary d
Completed the first round of GMP certificate expiration re inspection for veterinary drugs, the production compliance and quality control system of the original non sterile veterinary drug raw material production line passed the official review, and the qualification validity period was successfully renewed
Veterinary Drug GMP Certificate
Through the on-site re inspection and acceptance of the 9th batch of veterinary drug GMP by the Shanghai Agriculture and Rural Commission in 2021, the acceptance scope covers non sterile raw materials (such as follicle stimulating hormone, chloroprostenol, chloroprostenol sodium, goserelin, luteinizing hormone releasing hormone A2, luteinizing hormone releasing hormone A3, D-chloroprostenol sodium), and is recommended as a GMP qualified production line. It will be accepted according to the revised version of GMP standards in 2020
Veterinary Drug Manufacturing Licence
Complete the renewal of the new version of the veterinary drug production license, with the current status being valid, and the license scope fully matching the non sterile veterinary drug raw material production line accepted by GMP
Re issuance of approval number for veterinary drug
Complete the reapplication for the expiration of approval numbers for core veterinary drug raw materials such as chloroprostol sodium, and ensure that all numbers remain valid. The product's compliance and production qualifications continue to cover the entire product line
